Disarm Therapeutics is a biotechnology company that creates disease-modifying therapeutics for patients with axonal degeneration. Its drugs prevent the loss of axons and treat neurological diseases including multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies that enable patients to avail treatment for acutediseases of the central, ocular, and peripheral nervous systems.

Biotechnology

Disarm Therapeutics

Raul Krauss

Molly B. Schlagel

Marco Passini

Liza Leventhal

Todd Bosanac

Robert Hughes

Tom Engber

Research and Molecular Discovery

Leadership Team

��

Teams at Disarm Therapeutics

Research and Molecular Discovery

Leadership Team

��������

Teams at Disarm Therapeutics

Research and Molecular Discovery

Leadership Team

��